Concepedia

Kamira Maharaj

KM

Statistics

Publications

7

Citations

208

H-Index

7

Active since

2014

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

CDG Therapeutics (United States)

Acetylon Pharmaceuticals (United States)

Tianjin Medical University General Hospital

Kamira Maharaj is an author at Moffitt Cancer Center specializing in immunology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2014–2025

7

Publications

7

Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology

Eva Sahakian, Jie Chen, John J. Powers et al. · Journal of Leukocyte Biology · 2017 · 63 citations · Full text

, , +12

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

Kamira Maharaj, John J. Powers, Alex Achille et al. · Blood Advances · 2020 · 63 citations · Full text

, , +17

HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model

Kamira Maharaj, John J. Powers, Melanie Mediavilla-Varela et al. · Frontiers in Immunology · 2020 · 30 citations · Full text

, , +17

Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia

Kamira Maharaj, John J. Powers, Alex Achille et al. · Blood Advances · 2018 · 20 citations · Full text

, , +17

Histone Deacetylase 6 (HDAC6) As a Regulator of Immune Check-Point Molecules in Chronic Lymphocytic Leukemia (CLL)

John J. Powers, Kamira Maharaj, Eva Sahakian et al. · Blood · 2014 · 11 citations

, , +13

1–5 of 7